Literature DB >> 17885421

NR4A nuclear orphan receptors: protective in vascular disease?

Thijs W H Pols1, Peter I Bonta, Carlie J M de Vries.   

Abstract

PURPOSE OF REVIEW: The nuclear orphan receptors Nur77 (NR4A1), Nurr1 (NR4A2) and NOR-1 (NR4A3) are known to be involved in T-cell apoptosis, brain development, and the hypothalamic-pituitary-adrenal axis. Here, we review our current understanding of the NR4A nuclear receptors in processes that are relevant to vascular disease. RECENT
FINDINGS: NR4A nuclear receptors have recently been described to play a role in metabolism by regulating gluconeogenesis, lipolysis, energy expenditure, and adipogenesis. The function of NR4A nuclear receptors has also extensively been investigated in cells crucial in vascular lesion formation, such as macrophages, endothelial cells and smooth muscle cells.
SUMMARY: The involvement of NR4A nuclear receptors in both metabolism and in processes in the vessel wall supports a substantial role for NR4A nuclear receptors in the development of vascular disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17885421     DOI: 10.1097/MOL.0b013e3282ef77d1

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  27 in total

1.  FHL2 protein is a novel co-repressor of nuclear receptor Nur77.

Authors:  Kondababu Kurakula; Erik van der Wal; Dirk Geerts; Claudia M van Tiel; Carlie J M de Vries
Journal:  J Biol Chem       Date:  2011-11-02       Impact factor: 5.157

2.  Angiopoietin-1 and vascular endothelial growth factor regulation of leukocyte adhesion to endothelial cells: role of nuclear receptor-77.

Authors:  Hodan Ismail; Mahroo Mofarrahi; Raquel Echavarria; Sharon Harel; Eric Verdin; Hyung W Lim; Zheng-Gen Jin; Jianxin Sun; Huiyan Zeng; Sabah N A Hussain
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-05-24       Impact factor: 8.311

3.  NR4A Orphan Nuclear Receptors in Cardiovascular Biology.

Authors:  Yue Zhao; Dennis Bruemmer
Journal:  Drug Discov Today Dis Mech       Date:  2009

4.  The nuclear receptor, Nor-1, markedly increases type II oxidative muscle fibers and resistance to fatigue.

Authors:  Michael A Pearen; Natalie A Eriksson; Rebecca L Fitzsimmons; Joel M Goode; Nick Martel; Sofianos Andrikopoulos; George E O Muscat
Journal:  Mol Endocrinol       Date:  2012-01-26

5.  Nuclear receptors Nur77 and Nurr1 modulate mesenchymal stromal cell migration.

Authors:  Marijke W Maijenburg; Christian Gilissen; Sara M Melief; Marion Kleijer; Kees Weijer; Anja Ten Brinke; Helene Roelofs; Claudia M Van Tiel; Joris A Veltman; Carlie J M de Vries; C Ellen van der Schoot; Carlijn Voermans
Journal:  Stem Cells Dev       Date:  2011-06-01       Impact factor: 3.272

6.  The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1.

Authors:  Xiao-Jun Feng; Hui Gao; Si Gao; Zhuoming Li; Hong Li; Jing Lu; Jiao-Jiao Wang; Xiao-Yang Huang; Min Liu; Jian Zou; Jian-Tao Ye; Pei-Qing Liu
Journal:  Br J Pharmacol       Date:  2015-03-26       Impact factor: 8.739

7.  Nuclear receptor Nr4a1 modulates both regulatory T-cell (Treg) differentiation and clonal deletion.

Authors:  Marlys S Fassett; Wenyu Jiang; Anna Morena D'Alise; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-15       Impact factor: 11.205

8.  Nr4a1 siRNA expression attenuates α-MSH regulated gene expression in 3T3-L1 adipocytes.

Authors:  S-C Mary Wang; Stephen A Myers; Natalie A Eriksson; Rebecca L Fitzsimmons; George E O Muscat
Journal:  Mol Endocrinol       Date:  2011-01-14

9.  Identification of protein-coding and non-coding RNA expression profiles in CD34+ and in stromal cells in refractory anemia with ringed sideroblasts.

Authors:  Mariana O Baratti; Yuri B Moreira; Fabiola Traina; Fernando F Costa; Sergio Verjovski-Almeida; Sara T Olalla-Saad
Journal:  BMC Med Genomics       Date:  2010-07-15       Impact factor: 3.063

10.  Dissecting the transcriptional networks underlying breast cancer: NR4A1 reduces the migration of normal and breast cancer cell lines.

Authors:  Annika N Alexopoulou; Maria Leao; Otavia L Caballero; Leonard Da Silva; Lynne Reid; Sunil R Lakhani; Andrew J Simpson; John F Marshall; A Munro Neville; Parmjit S Jat
Journal:  Breast Cancer Res       Date:  2010-07-19       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.